Robust and Rapid Method for Analysis of Active Pharmaceutical Ingredients in Multi-Component Cold and Flu Medication

Significance of the Topic

Multicomponent over-the-counter cold and flu remedies combine a variety of active pharmaceutical ingredients (APIs) with widely differing chemical properties. Reliable, rapid analysis of all APIs in a single run is critical for formulation development, quality control, and identification of unknown or degraded compounds. Integrating mass detection into ultra-high-performance liquid chromatography (UHPLC) workflows enhances specificity and peak purity assessment.

Objectives and Overview

This study aimed to develop a robust, MS-compatible UHPLC method for simultaneous separation and quantitation of eight common cold and flu APIs: acetaminophen, dextromethorphan hydrobromide, phenylephrine hydrochloride, chlorpheniramine maleate, ibuprofen, pseudoephedrine hydrochloride, guaifenesin, and doxylamine succinate. A systematic three-step protocol—scouting, screening, and optimization—was applied to meet stringent separation criteria (resolution ≥2.0, tailing ≤1.5, k′ ≥2.0).

Methodology and Instrumentation

Sample Preparation:

• Individual stock solutions (1 mg/mL in methanol) combined and diluted to 100 µg/mL.
• Commercial syrup, tablet, and caplet formulations diluted to match working concentration and filtered through 0.2 µm filters.

Chromatographic Conditions:

• System: ACQUITY UPLC H-Class PLUS with Column Manager and Solvent Select Valve.
• Column: ACQUITY UPLC BEH C18, 2.1 × 50 mm, 1.7 µm, at 40 °C.
• Mobile Phase A: 10 mM ammonium acetate in water with 0.2% ammonium hydroxide.
• Mobile Phase B: Methanol with 0.2% ammonium hydroxide.
• Gradient: 5–90% B over 5 minutes, total run 7.5 minutes, flow 0.6 mL/min, injection 1 µL.

MS Conditions:

• Detector: ACQUITY QDa Mass Detector (ESI+, ESI–), probe 600 °C, capillary 0.8 kV, cone 5 V, scan 100–400 m/z.
• Data acquired and processed in Empower 3 CDS, using UV (215 nm) and MS peak tracking.

Main Results and Discussion

Scouting identified high-pH mobile phases as optimal for retention and separation. Screening compared CSH C18 and BEH C18 columns with methanol and acetonitrile; BEH C18 with methanol ranked highest by resolution and tailing metrics. Optimization introduced 10 mM ammonium acetate with 0.2% ammonium hydroxide, reducing tailing and enhancing selectivity. System suitability tests (five replicates) showed retention time RSDs <0.1%, tailing ≤1.4, and consistent peak areas. Reproducibility across three BEH C18 column batches confirmed method robustness. Analysis of commercial syrup, caplet, and tablet formulations demonstrated spectral homogeneity of each API via UV peak purity and MS spectra, with no excipient interference.

Benefits and Practical Applications

This method offers:

• Rapid, seven-minute analysis for eight APIs in complex formulations.
• High confidence in peak identification through MS tracking.
• Compatibility with routine QC and identification of unknowns during development.
• Reproducible performance across column lots and formulation types.

Future Trends and Opportunities

Further developments may include coupling with high-resolution MS for impurity profiling, automation of method scouting through software-driven design, expansion to broader API classes, and real-time process analytics in manufacturing. Integration with multivariate data analysis could streamline method transfer and validation.

Conclusion

A systematic UHPLC-MS approach enabled rapid, robust simultaneous determination of eight APIs in multi-component cold and flu products. The final method meets USP criteria for resolution, tailing, and reproducibility, and is directly applicable to quality control and formulation studies.

Instrumentation Used

• ACQUITY UPLC H-Class PLUS System with Column Manager and Solvent Select Valve
• ACQUITY UPLC PDA Detector (200–500 nm)
• ACQUITY QDa Mass Detector
• ACQUITY UPLC BEH C18 Columns
• Empower 3 Chromatography Data Software

References

1. Borkar N, Sawant S. Review of Simultaneous Determination of Analytes by High Performance Liquid Chromatography in Multicomponent Cough and Cold Oral Drug Products. Int J PharmTech Res. 2011;3(3):1339–1345.
2. Siddareddy K, Reddy MR, Sreenamulu J. Simultaneous Estimation of Acetaminophen, Phenylephrine HCl, Guaifenesin, and Dextromethorphan HBr in Reversed Phase Ultra Performance Liquid Chromatography. Res J Pharm Biol Chem Sci. 2016;7(6):2274–2281.
3. Yehia AM, Essam HM. Development and Validation of a Generic High-Performance Liquid Chromatography for the Simultaneous Separation and Determination of Six Cough Ingredients: Robustness Study on Core-Shell Particles. J Sep Sci. 2016;39:3357–3367.
4. Maziarz M, McCarthy SM, Wrona M. Improving Effectiveness in Method Development by Using a Systematic Screening Protocol for a USP Method (Metoclopramide HCl and Related Substances). Waters App Note. 2014;720005026EN.
5. United States Pharmacopeia. General Chapter <621> Chromatography. USP45-NF40. 2017.